Literature DB >> 31855238

Diagnosis and Management of Primary Dysmenorrhea.

Kimberly A Kho1, Jessica K Shields1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31855238     DOI: 10.1001/jama.2019.16921

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Pelvic floor symptoms in cisgender women with Ehlers-Danlos syndrome: an international survey study.

Authors:  Olga Kciuk; Qixuan Li; Ella Huszti; Colleen D McDermott
Journal:  Int Urogynecol J       Date:  2022-06-25       Impact factor: 2.894

2.  Oral traditional Chinese patent medicines combined with non-steroidal anti-inflammatory drugs for primary dysmenorrhea: A protocol for Bayesian network meta-analysis and systematic review.

Authors:  Zhe Chen; Yingying Peng; Xiaoyu Qiang; Geliang Song; Fengwen Yang; Bo Pang; Hui Wang
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

3.  Comparing dysmenorrhea beliefs and self-management techniques across symptom-based phenotypes.

Authors:  Sarah Katherine Rogers; Kevin L Rand; Chen Xiao Chen
Journal:  J Clin Nurs       Date:  2021-03-24       Impact factor: 4.423

4.  Efficacy and safety of external therapy of TCM for primary dysmenorrhea: A protocol for systematic review and meta-analysis.

Authors:  Haiyu Zhu; Hongyi Guan; Tingwei Ding; Yunpeng Bi; Yue Zhuo; Yuanyuan Chen; Tie Li; Zhihong Wang
Journal:  Medicine (Baltimore)       Date:  2022-05-06       Impact factor: 1.817

5.  The efficacy and safety of simple-needling for the treatment of primary dysmenorrhea compared with ibuprofen: A systematic review and meta-analysis.

Authors:  Yichen Xuan; Haifeng Zhang; Duanyong Liu; Yiyong Huang; Linhui Li; Qianan Cao; Yong Fu
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

6.  Comparative evaluation of low-level light therapy and ethinyl estradiol and desogestrel combined oral contraceptive for clinical efficacy and regulation of serum biochemical parameters in primary dysmenorrhoea: a prospective randomised multicentre trial.

Authors:  Shiyang Zhu; Xiao Ma; Xuesong Ding; Jingwen Gan; Yan Deng; Yanfang Wang; Aijun Sun
Journal:  Lasers Med Sci       Date:  2022-01-14       Impact factor: 3.161

7.  Stroke risk associated with NSAIDs uses in women with dysmenorrhea: A population-based cohort study.

Authors:  Ya-Wen Lin; Jong-Yi Wang; Ming-Hung Lin
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

8.  A systematic review of Tuina for women with primary dysmenorrhea: A protocol for systematic review and meta-analysis.

Authors:  Yueming Lv; Huichao Feng; Fushi Jing; Yonghui Ren; Qian Zhuang; Jiao Rong; Qi Pan; Mengtian Li; Jing Zhang; Fujie Jing
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

Review 9.  Moxibustion for Primary Dysmenorrhea: An Adjuvant Therapy for Pain Relief.

Authors:  Sian Pan; Shaohua Wang; Juan Li; Hanyu Yuan; Xiao Xue; Yu Liu; Zenghui Yue
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-27       Impact factor: 2.629

10.  The effectiveness of acupoint application of traditional Chinese medicine in treating primary dysmenorrhea: A protocol for meta-analysis and data mining.

Authors:  Yanze Liu; Lin Yao; Bing Yan; Hailin Jiang; Jinying Zhao; Jiazhen Cao; Mengyuan Li; Xiaona Liu; Lijuan Ha; Li Tie; Chengyu Liu; Fuchun Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.